Regencell Bioscience
3 hedge funds and large institutions have $32.3K invested in Regencell Bioscience in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$18.2K |
| 2 |
2
Morgan Stanley
New York
|
$7.64K |
Top Sellers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $18.2K | +$3.29K | +4,598 | +22% |
|
|
2
Morgan Stanley
New York
| $7.64K | +$1.47K | +2,052 | +24% |
|
3
BlackRock
New York
| $6.47K | – | – | – |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| – | -$216K | -259,008 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$12K | -14,136 | Closed |
|